Forwarded from 업사이드[UPSIDE]📈
-> Optum Rx는 오늘 아침 산도스의 Hyrimoz(아달리무맙-아다즈)와 Boehinger Ingelheim의 Cyltezo(아달리무맙-adbm)를 Humira와 동등한 처방집에 포함할 것이라고 발표.
https://www.managedhealthcareexecutive.com/view/optum-rx-picks-hyrimoz-and-cyltezo-for-its-formulary
Please open Telegram to view this post
VIEW IN TELEGRAM
Managed Healthcare Executive
Optum Rx Picks Hyrimoz and Cyltezo for Its Formulary
The Sandoz's and Boehinger Ingelheim's Humira biosimilars will join Amgen's Amjevita on the formulary of UnitedHealth Group's PBM. Cyltezo may have a marketing edge because of its interchangeability designation.